Related Experiment Video
Updated: May 21, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
Statistical challenges in the development and evaluation of marker-based clinical tests
1Biometric Research Branch and Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Boulevard, EPN 8126, Bethesda, MD 20892-7434, USA. McShaneL@CTEP.NCI.NIH.gov
BMC Medicine
|May 31, 2012
Summary
New technologies enable comprehensive analysis of biological markers for disease prediction and treatment. Statistical challenges in validating these marker-based tests are critical for clinical decision-making.
Area of Science:
- Biomarker Discovery
- Translational Science
- Clinical Diagnostics
Background:
- Advancements in high-throughput technologies allow for the assessment of numerous variations in DNA, RNA, proteins, and chromosomes.
- Biological markers, individually or as signatures, hold significant potential for various clinical applications including disease risk assessment, early detection, and treatment selection.
Purpose of the Study:
- To highlight the statistical challenges inherent in the translational research of biomarkers.
- To emphasize the importance of robust statistical methods in developing and validating clinically useful marker-based tests for therapeutic decision-making.
Main Methods:
- This commentary focuses on the statistical aspects of translational marker research.
- It addresses the development and validation of marker-based tests.
Main Results:
- The commentary identifies numerous statistical challenges in translational marker research.
- It underscores the need for statistical rigor in translating research findings into clinical practice.
Conclusions:
- Successful clinical translation of marker-based tests requires interdisciplinary collaboration and robust statistical validation.
- Addressing statistical challenges is crucial for ensuring the clinical utility of biomarkers in guiding therapeutic decisions.
Related Concept Videos
01:13Sensitivity, Specificity, and Predicted Value
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:13Accuracy and Errors in Hypothesis Testing
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
01:04Significance Testing: Overview
Significance testing is a set of statistical methods used to test whether a claim about a parameter is valid. In analytical chemistry, significance testing is used primarily to determine whether the difference between two values comes from determinate or random errors. The effect of a particular change in the measurement protocol, analyst, or sample itself can cause a deviation from the expected result. In the case of a suspected deviation/outlier, we need to be able to confirm mathematically...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:13Multiple Comparison Tests
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...